Underwriter | Biotechnology |
Date |
Offering |
12/31/06 |
Offering |
After-Market |
AG Edwards |
BioMimetic Therapeutics Inc. (BMTI) (IPO) |
5/12/06 |
$8 |
$13.19 |
$36.8 |
+65% |
Ardour Capital |
Metabolix Inc. (MBLX) (IPO) |
11/17/06 |
$14 |
$18.94 |
$109.5 |
+35% |
Banc of America |
Acadia Pharmaceuticals Inc. (ACAD) (co-lead) |
4/27/06 |
$12 |
$8.79 |
$59.4 |
-27% |
|
Acorda Therapeutics Inc. (ACOR) (IPO; lead) |
2/10/06 |
$6 |
$15.84 |
$36.5 |
+150% |
|
Adolor Corp. (ADLR) |
2/16/06 |
$25 |
$7.52 |
$143.8 |
-70% |
|
Alnylam Pharmaceuticals Inc. (ALNY)(co-lead) |
1/31/06 |
$13 |
$21.40 |
$66.5 |
+65% |
|
Alnylam Pharmaceuticals Inc. (ALNY) (lead) |
12/12/06 |
$22 |
$21.40 |
$103.4 |
-3% |
|
Exelixis Inc. (EXEL) |
10/5/06 |
$8.40 |
$9 |
$96.6 |
+7% |
|
Labopharm Inc. (Canada; DDSS) (co-lead) |
4/28/06 |
$8 |
$5.87 |
$101.2 |
-27% |
|
Trubion Pharmaceuticals Inc. (TRBN) (IPO; co-lead) |
10/18/06 |
$13 |
$18.01 |
$52 |
+39% |
|
Valera Pharmaceuticals Inc. (VLRX) (IPO; co-lead) |
2/2/06 |
$9 |
$8.10 |
$34.8 |
-10% |
|
Vanda Pharmaceuticals Inc. (VNDA) (IPO; co-lead) |
4/12/06 |
$10 |
$24.65 |
$59.6 |
+147% |
Bear, Stearns & Co. |
Alexion Pharmaceuticals Inc. (ALXN) |
11/15/06 |
$43 |
$40.39 |
$148.4 |
-6% |
|
Amylin Pharmaceuticals Inc. (AMLN) |
3/30/06 |
$46.50 |
$36.07 |
$534.8 |
-22% |
|
Celgene Corp. (CELG) |
11/3/06 |
$51.60 |
$57.53 |
$1,032 |
+11% |
|
Novacea Inc. (NOVC) (IPO; co-lead) |
5/10/06 |
$6.50 |
$5.66 |
$44.9 |
-13% |
Brean Murray, |
Genitope Corp. (GTOP) |
2/7/06 |
$8.50 |
$3.52 |
$62.6 |
-59% |
|
Sirna Therapeutics Inc. (RNAI) |
5/24/06 |
$5 |
$13** |
$51.8 |
+160% |
Canaccord Adams |
Acadia Pharmaceuticals Inc. (ACAD) |
4/27/06 |
$12 |
$8.79 |
$59.4 |
-27% |
|
Labopharm Inc. (Canada; DDSS) |
4/28/06 |
$8 |
$5.87 |
$101.2 |
-27% |
C.E. Unterberg, |
Insmed Inc. (INSM) (co-lead) |
3/10/06 |
$2 |
$0.88 |
$46 |
-56% |
CIBC World |
Arena Pharmaceuticals Inc. (ARNA) (co-lead) |
1/27/06 |
$16.90 |
$12.91 |
$179.8 |
-24% |
|
Arena Pharmaceuticals Inc. (ARNA) (co-lead) |
12/8/06 |
$13.21 |
$12.91 |
$174.7 |
-2% |
|
Achillion Pharmaceuticals Inc. (ACHN) (IPO; co-lead) |
10/26/06 |
$11.50 |
$16.11 |
$59.5 |
+40% |
|
Indevus Pharmaceuticals Inc. (IDEV) |
6/28/06 |
$4.65 |
$7.10 |
$37.43 |
+53% |
|
MannKind Corp. (MNKD) |
12/7/06 |
$17.42 |
$16.49 |
$400.7 |
-5% |
|
Omrix Bio-pharmaceuticals Inc. (OMRI) (IPO; co-lead) |
4/20/06 |
$10 |
$30.26 |
$39.6 |
+203% |
|
Omrix Bio-pharmaceuticals Inc. (OMRI) |
12/15/06 |
$32 |
$30.26 |
$48 |
-5% |
|
SGX Pharmaceuticals Inc. (SGXP) (IPO; co-lead) |
1/31/06 |
$6 |
$3.50 |
$24.9 |
-42% |
|
Sirna Therapeutics Inc. (RNAI) |
5/24/06 |
$5 |
$13** |
$51.8 |
+160% |
|
Targacept Inc. (TRGT) (IPO) |
4/12/06 |
$9 |
$9.05 |
$45 |
+1% |
Citigroup |
Celgene Corp. (CELG) |
11/3/06 |
$51.60 |
$57.53 |
$1,032 |
+11% |
|
Omrix Bio-pharmaceuticals Inc. (OMRI) (co-lead) |
12/15/06 |
$32 |
$30.26 |
$48 |
-5% |
Cowen & Co. |
Achillion Pharmaceuticals Inc. (ACHN) (IPO; co-lead) |
10/26/06 |
$11.50 |
$16.11 |
$59.5 |
+40% |
|
Acorda Therapeutics Inc. (ACOR) (IPO) |
2/10/06 |
$6 |
$15.84 |
$36.5 |
+150% |
|
Affymax Inc. (AFFY) (IPO) |
12/15/06 |
$25 |
$34.04 |
$106.4 |
+36% |
|
Alexion Pharmaceuticals Inc. (ALXN) |
11/15/06 |
$43 |
$40.39 |
$148.4 |
-6% |
|
Alnylam Pharmaceuticals Inc. (ALNY) |
1/31/06 |
$13 |
$21.40 |
$66.5 |
+65% |
|
Altus Pharmaceuticals Inc. (ALTU) (IPO) |
1/26/06 |
$15 |
$18.85 |
$105 |
+26% |
|
Arena Pharmaceuticals Inc. (ARNA) |
1/27/06 |
$16.90 |
$12.91 |
$179.8 |
-24% |
|
Arena Pharmaceuticals Inc. (ARNA) (co-lead) |
12/8/06 |
$13.21 |
$12.91 |
$174.7 |
-2% |
|
BioMarin Pharmaceutical Inc. (BMRN) |
3/24/06 |
$13 |
$16.39 |
$134.6 |
+26% |
|
Emergent BioSolutions Inc. (NYSE:EBS) (IPO; co-lead) |
11/15/06 |
$12.50 |
$11.16 |
$62.6 |
-11% |
|
Exelixis Inc. (EXEL) (co-lead) |
10/5/06 |
$8.40 |
$9 |
$96.6 |
+7% |
|
Illumina Inc. (ILMN) |
5/19/06 |
$25.50 |
$39.31 |
$102.6 |
+54% |
|
Iomai Corp. (IOMI) (IPO; co-lead) |
2/1/06 |
$7 |
$4.98 |
$35 |
-29% |
|
Kosan Biosciences Inc. (KOSN) (co-lead) |
3/30/06 |
$5 |
$5.55 |
$25.5 |
+11% |
|
Novacea Inc. (NOVC) (IPO; co-lead) |
5/10/06 |
$6.50 |
$5.66 |
$44.9 |
-13% |
|
Replidyne Inc. (RDYN) (IPO) |
6/28/06 |
$10 |
$5.74 |
$50 |
-43% |
Credit Suisse |
Alexion Pharmaceuticals Inc. (ALXN) |
11/15/06 |
$43 |
$40.39 |
$148.4 |
-6% |
|
Cell Genesys Inc. (CEGE) (lead) |
9/7/06 |
$4.40 |
$3.39 |
$25.3 |
-23% |
|
Kosan Biosciences Inc. (KOSN) (co-lead) |
3/30/06 |
$5 |
$5.55 |
$25.5 |
+11% |
Dawson James |
Biopure Corp. (BPUR) (lead) |
12/8/06 |
$0.64 |
$0.48 |
$18.1 |
-33% |
|
Viragen Inc. (AMEX:VRA) (lead) |
10/31/06 |
$0.26 |
$0.15 |
$18.7 |
-42% |
Deutsche Bank |
BioMimetic Therapeutics Inc. (BMTI) (IPO; co-lead) |
5/12/06 |
$8 |
$13.19 |
$36.8 |
+65% |
|
Cadence Pharmaceuticals Inc. (CADX) (IPO; co-lead) |
10/25/06 |
$9 |
$12.32 |
$62.1 |
+37% |
|
Dyax Corp. (DYAX) (lead) |
3/9/06 |
$5.65 |
$3.03 |
$31.1 |
-46% |
|
Nuvelo Inc. (NUVO) (co-lead) |
1/31/06 |
$16 |
$4 |
$119.6 |
-75% |
|
Targacept Inc. (TRGT) (IPO; co-lead) |
4/12/06 |
$9 |
$9.05 |
$45 |
+1% |
|
XenoPort Inc. (XNPT) |
6/21/06 |
$17 |
$24.55 |
$76.5 |
+44% |
Dundee Securities |
Labopharm Inc. (Canada; DDSS) |
4/28/06 |
$8 |
$5.87 |
$101.2 |
-27% |
Ferris, Baker Watts |
Immtech International Inc. (AMEX:IMM) (lead) |
2/13/06 |
$8 |
$7.60 |
$16 |
-5% |
First Albany Capital |
BioMimetic Therapeutics Inc. (BMTI) (IPO) |
5/12/06 |
$8 |
$13.19 |
$36.8 |
+65% |
|
Catalyst Pharmaceutical Partners Inc. (CPRX) (IPO; co-lead) |
11/9/06 |
$6 |
$4.83 |
$20.1 |
-20% |
|
Iomai Corp. (IOMI) (IPO) |
2/1/06 |
$7 |
$4.98 |
$35 |
-29% |
|
Valera Pharmaceuticals Inc. (VLRX) (IPO) |
2/2/06 |
$9 |
$8.10 |
$34.8 |
-10% |
Fortis Securities |
Arena Pharmaceuticals Inc. (ARNA) |
12/8/06 |
$13.21 |
$12.91 |
$174.7 |
-2% |
|
Valera Pharmaceuticals Inc. (VLRX) (IPO) |
2/2/06 |
$9 |
$8.10 |
$34.8 |
-10% |
Friedman Billings Ramsey |
Celgene Corp. (CELG) |
11/3/06 |
$51.60 |
$57.53 |
$1,032 |
+11% |
Goldman, Sachs |
Alexion Pharmaceuticals Inc. (ALXN) (co-lead) |
11/15/06 |
$43 |
$40.39 |
$148.4 |
-6% |
|
Amylin Pharmaceuticals Inc. (AMLN) (co-lead) |
3/30/06 |
$46.50 |
$36.07 |
$534.8 |
-22% |
|
Celgene Corp. (CELG) |
11/3/06 |
$51.60 |
$57.53 |
$1,032 |
+11% |
|
Exelixis Inc. (EXEL) (co-lead) |
10/5/06 |
$8.40 |
$9 |
$96.6 |
+7% |
|
Illumina Inc. (ILMN) (co-lead) |
5/19/06 |
$25.50 |
$39.31 |
$102.6 |
+54% |
|
Medarex Inc. (MEDX) (co-lead) |
4/7/06 |
$11.75 |
$14.79 |
$135.1 |
+26% |
HSBC Securities |
Emergent BioSolutions Inc. (NYSE:EBS) (IPO) |
11/15/06 |
$12.50 |
$11.16 |
$62.6 |
-11% |
|
Novacea Inc. (NOVC) (IPO) |
5/10/06 |
$6.50 |
$5.66 |
$44.9 |
-13% |
|
Theravance Inc. (THRX) |
2/1/06 |
$28.50 |
$30.89 |
$131.1 |
+8% |
Janney |
Medarex Inc. (MEDX) |
4/7/06 |
$11.75 |
$14.79 |
$135.1 |
+26% |
Jefferies & Co. |
Advanced Magnetics Inc. (AMAG) |
12/7/06 |
$62 |
$59.72 |
$130.4 |
-4% |
|
Metabolix Inc. (MBLX) (IPO) |
11/17/06 |
$14 |
$18.94 |
$109.5 |
+35% |
|
Osiris Therapeutics Inc. (OSIR) (IPO; lead) |
8/4/06 |
$11 |
$25.32 |
$38.5 |
+130% |
JMP Securities |
Acadia Pharmaceuticals Inc. (ACAD) |
4/27/06 |
$12 |
$8.79 |
$59.4 |
-27% |
|
Achillion Pharmaceuticals Inc. (ACHN) (IPO) |
10/26/06 |
$11.50 |
$16.11 |
$59.5 |
+40% |
|
Alexza Pharmaceuticals Inc. (ALXA) (IPO) |
3/8/06 |
$8 |
$11.39 |
$50.6 |
+42% |
|
Cadence Pharmaceuticals Inc. (CADX) (IPO) |
10/25/06 |
$9 |
$12.32 |
$62.1 |
+37% |
|
Celgene Corp. (CELG) |
11/3/06 |
$51.60 |
$57.53 |
$1,032 |
+11% |
|
Cerus Corp. (CERS) (co-lead) |
3/16/06 |
$8.75 |
$5.86 |
$45.3 |
-33% |
|
Indevus Pharmaceuticals Inc. (IDEV) |
6/28/06 |
$4.65 |
$7.10 |
$37.43 |
+53% |
|
SGX Pharmaceuticals Inc. (SGXP) (IPO) |
1/31/06 |
$6 |
$3.50 |
$24.9 |
-42% |
JP Morgan |
Adolor Corp. (ADLR) |
2/16/06 |
$25 |
$7.52 |
$143.8 |
-70% |
|
Celgene Corp. (CELG) (co-lead) |
11/3/06 |
$51.60 |
$57.53 |
$1,032 |
+11% |
|
Emergent BioSolutions Inc. (NYSE:EBS)(IPO; co-lead) |
11/15/06 |
$12.50 |
$11.16 |
$62.6 |
-11% |
|
MannKind Corp. (MNKD) (co-lead) |
12/7/06 |
$17.42 |
$16.49 |
$400.7 |
-5% |
|
Medarex Inc. (MEDX) (co-lead) |
4/7/06 |
$11.75 |
$14.79 |
$135.1 |
+26% |
|
Nuvelo Inc. (NUVO) (co-lead) |
1/31/06 |
$16 |
$4 |
$119.6 |
-75% |
|
Sirna Therapeutics Inc. (RNAI) (co-lead) |
5/24/06 |
$5 |
$13** |
$51.8 |
+160% |
|
Vanda Pharmaceuticals Inc. (VNDA)(IPO; co-lead) |
4/12/06 |
$10 |
$24.65 |
$59.6 |
+147% |
Lazard Capital |
Acorda Therapeutics Inc. (ACOR) (IPO) |
2/10/06 |
$6 |
$15.84 |
$36.5 |
+150% |
|
Celgene Corp. (CELG) |
11/3/06 |
$51.60 |
$57.53 |
$1,032 |
+11% |
|
Insmed Inc. (INSM) (co-lead) |
3/10/06 |
$2 |
$0.88 |
$46 |
-56% |
|
Osiris Therapeutics Inc. (OSIR) (IPO) |
8/4/06 |
$11 |
$25.32 |
$38.5 |
+130% |
|
Targacept Inc. (TRGT) (IPO) |
4/12/06 |
$9 |
$9.05 |
$45 |
+1% |
|
Trubion Pharmaceuticals Inc. (TRBN) (IPO) |
10/18/06 |
$13 |
$18.01 |
$52 |
+39% |
Leerink Swann & Co. |
Arena Pharmaceuticals Inc. (ARNA) |
12/8/06 |
$13.21 |
$12.91 |
$174.7 |
-2% |
|
BioMarin Pharmaceutical Inc. (BMRN) |
3/24/06 |
$13 |
$16.39 |
$134.6 |
+26% |
|
Celgene Corp. (CELG) |
11/3/06 |
$51.60 |
$57.53 |
$1,032 |
+11% |
|
Indevus Pharmaceuticals Inc. (IDEV) |
6/28/06 |
$4.65 |
$7.10 |
$37.43 |
+53% |
|
Labopharm Inc. (Canada; DDSS) |
4/28/06 |
$8 |
$5.87 |
$101.2 |
-27% |
|
MannKind Corp. (MNKD) |
12/7/06 |
$17.42 |
$16.49 |
$400.7 |
-5% |
|
Omrix Bio-pharmaceuticals Inc. (OMRI) (IPO) |
4/20/06 |
$10 |
$30.26 |
$39.6 |
+203% |
|
Osiris Therapeutics Inc. (OSIR) (IPO) |
8/4/06 |
$11 |
$25.32 |
$38.5 |
+130% |
|
Sirna Therapeutics Inc. (RNAI) |
5/24/06 |
$5 |
$13** |
$51.8 |
+160% |
Lehman Brothers |
Acadia Pharmaceuticals Inc. (ACAD) (co-lead) |
4/27/06 |
$12 |
$8.79 |
$59.4 |
-27% |
|
Adolor Corp. (ADLR) (lead) |
2/16/06 |
$25 |
$7.52 |
$143.8 |
-70% |
|
Amylin Pharmaceuticals Inc. (AMLN) |
3/30/06 |
$46.50 |
$36.07 |
$534.8 |
+22% |
|
CV Therapeutics Inc. (CVTX; co-lead) |
8/16/06 |
$9.50 |
$13.96 |
$98.3 |
+47% |
Lehman Brothers |
Nuvelo Inc. (NUVO) |
1/31/06 |
$16 |
$4 |
$119.6 |
-75% |
|
Tercica Inc. (TRCA) (lead) |
1/24/06 |
$6.40 |
$5 |
$36.8 |
-22% |
Merrill Lynch & Co. |
Altus Pharmaceuticals Inc. (ALTU) (IPO; co-lead) |
1/26/06 |
$15 |
$18.85 |
$105 |
+26% |
|
BioMarin Pharmaceutical Inc. (BMRN) (lead) |
3/24/06 |
$13 |
$16.39 |
$134.6 |
+26% |
|
Cadence Pharmaceuticals Inc. (CADX) (IPO; co-lead) |
10/25/06 |
$9 |
$12.32 |
$62.1 |
+37% |
|
Celgene Corp. (CELG) (co-lead) |
11/3/06 |
$51.60 |
$57.53 |
$1,032 |
+11% |
|
CV Therapeutics Inc. (CVTX) (co-lead) |
8/16/06 |
$9.50 |
$13.96 |
$98.3 |
+47% |
|
Illumina Inc. (ILMN) (co-lead) |
5/19/06 |
$25.50 |
$39.31 |
$102.6 |
+54% |
|
Labopharm Inc. (Canada; DDSS) (co-lead) |
4/28/06 |
$8 |
$5.87 |
$101.2 |
-27% |
|
MannKind Corp. (MNKD) (co-lead) |
12/7/06 |
$17.42 |
$16.49 |
$400.7 |
-5% |
|
Replidyne Inc. (RDYN) (IPO; co-lead) |
6/28/06 |
$10 |
$5.74 |
$50 |
-43% |
|
Theravance Inc. (THRX) (lead) |
2/1/06 |
$28.50 |
$30.89 |
$131.1 |
+8% |
|
Vertex Pharmaceuticals Inc. (VRTX) (co-lead) |
9/14/06 |
$33 |
$37.42 |
$300.3 |
+13% |
Montgomery & Co. |
Arena Pharmaceuticals Inc. (ARNA) |
1/27/06 |
$16.90 |
$12.91 |
$179.8 |
-24% |
Morgan Joseph |
Arena Pharmaceuticals Inc. (ARNA) |
1/27/06 |
$16.90 |
$12.91 |
$179.8 |
-24% |
Morgan Joseph |
Arena Pharmaceuticals Inc. (ARNA) |
12/8/06 |
$13.21 |
$12.91 |
$174.7 |
-2% |
Morgan Stanley & Co. |
Advanced Magnetics Inc. (AMAG) (co-lead) |
12/7/06 |
$62 |
$59.72 |
$130.4 |
-4% |
|
Alexion Pharmaceuticals Inc. (ALXN) (co-lead) |
11/15/06 |
$43 |
$40.39 |
$148.4 |
-6% |
|
Affymax Inc. (AFFY) (IPO; lead) |
12/15/06 |
$25 |
$34.04 |
$106.4 |
+36% |
|
Alnylam Pharmaceuticals Inc. (ALNY) (co-lead) |
1/31/06 |
$13 |
$21.40 |
$66.5 |
+65% |
|
Amylin Pharmaceuticals Inc. (AMLN) (co-lead) |
3/30/06 |
$46.50 |
$36.07 |
$534.8 |
-22% |
|
Altus Pharmaceuticals Inc. (ALTU) (IPO; co-lead) |
1/26/06 |
$15 |
$18.85 |
$105 |
+26% |
|
Celgene Corp. (CELG) |
11/3/06 |
$51.60 |
$57.53 |
$1,032 |
+11% |
|
Replidyne Inc. (RDYN) (IPO; co-lead) |
6/28/06 |
$10 |
$5.74 |
$50 |
-43% |
|
Trubion Pharmaceuticals Inc. (TRBN) (IPO; co-lead) |
10/18/06 |
$13 |
$18.01 |
$52 |
+39% |
|
Vertex Pharmaceuticals Inc. (VRTX) (co-lead) |
9/14/06 |
$33 |
$37.42 |
$300.3 |
+13% |
|
XenoPort Inc. (XNPT) (lead) |
6/21/06 |
$17 |
$24.55 |
$76.5 |
+44% |
Needham & Co. |
Arena Pharmaceuticals Inc. (ARNA) |
1/27/06 |
$16.90 |
$12.91 |
$179.8 |
-24% |
|
Arena Pharmaceuticals Inc. (ARNA) |
12/8/06 |
$13.21 |
$12.91 |
$174.7 |
-2% |
Oppenheimer & Co. |
Arena Pharmaceuticals Inc. (ARNA) |
12/8/06 |
$13.21 |
$12.91 |
$174.7 |
-2% |
|
Omrix Biopharmaceuticals Inc. (OMRI) (IPO) |
4/20/06 |
$10 |
$30.26 |
$39.6 |
+203% |
Orion Securities |
Labopharm Inc. (Canada; DDSS) |
4/28/06 |
$8 |
$5.87 |
$101.2 |
-27% |
Pacific Growth |
Adolor Corp. (ADLR) |
2/16/06 |
$25 |
$7.52 |
$143.8 |
-70% |
|
Alexza Pharmaceuticals Inc. (ALXA) (IPO; co-lead) |
3/8/06 |
$8 |
$11.39 |
$50.6 |
+42% |
|
BioMarin Pharmaceutical Inc. (BMRN) |
3/24/06 |
$13 |
$16.39 |
$134.6 |
+26% |
|
BioMimetic Therapeutics Inc. (BMTI) (IPO; co-lead) |
5/12/06 |
$8 |
$13.19 |
$36.8 |
+65% |
|
Cadence Pharmaceuticals Inc. (CADX) (IPO) |
10/25/06 |
$9 |
$12.32 |
$62.1 |
+37% |
|
Dynavax Technologies Corp. (DVAX) (lead) |
10/4/06 |
$4.40 |
$9.18 |
$31.4 |
+109% |
|
Novacea Inc. (NOVC) (IPO) |
5/10/06 |
$6.50 |
$5.66 |
$44.9 |
-13% |
|
Replidyne Inc. (RDYN) (IPO) |
6/28/06 |
$10 |
$5.74 |
$50 |
-43% |
|
Targacept Inc. (TRGT) (IPO; co-lead) |
4/12/06 |
$9 |
$9.05 |
$45 |
+1% |
|
Trubion Pharmaceuticals Inc. (TRBN) (IPO) |
10/18/06 |
$13 |
$18.01 |
$52 |
+39% |
|
XenoPort Inc. (XNPT) |
6/21/06 |
$17 |
$24.55 |
$76.5 |
+44% |
Piper Jaffray & Co. |
Acadia Pharmaceuticals Inc. (ACAD) |
4/27/06 |
$12 |
$8.79 |
$59.4 |
-27% |
Piper Jaffray & Co. |
Acorda Therapeutics Inc. (ACOR) (IPO) |
2/10/06 |
$6 |
$15.84 |
$36.5 |
+150% |
|
Alexion Pharmaceuticals Inc. (ALXN) |
11/15/06 |
$43 |
$40.39 |
$148.4 |
-6% |
|
Alexza Pharmaceuticals Inc. (ALXA) (IPO; co-lead) |
3/8/06 |
$8 |
$11.39 |
$50.6 |
+42% |
|
Alnylam Pharmaceuticals Inc. (ALNY) |
1/31/06 |
$13 |
$21.40 |
$66.5 |
+65% |
|
Arena Pharmaceuticals Inc. (ARNA) |
1/27/06 |
$16.90 |
$12.91 |
$179.8 |
-24% |
|
Arena Pharmaceuticals Inc. (ARNA) (co-lead) |
12/8/06 |
$13.21 |
$12.91 |
$174.7 |
-2% |
|
Celgene Corp. (CELG) |
11/3/06 |
$51.60 |
$57.53 |
$1,032 |
+11% |
|
Exelixis Inc. (EXEL) |
10/5/06 |
$8.40 |
$9 |
$96.6 |
+7% |
|
Metabolix Inc. (MBLX) (IPO; lead) |
11/17/06 |
$14 |
$18.94 |
$109.5 |
+35% |
|
Sangamo BioSciences Inc. (SGMO) (lead) |
6/15/06 |
$6.50 |
$6.60 |
$20.2 |
+2% |
|
SGX Pharmaceuticals Inc. (SGXP) (IPO; co-lead) |
1/31/06 |
$6 |
$3.50 |
$24.9 |
-42% |
Punk, Ziegel & Co. |
Genitope Corp. (GTOP) |
2/7/06 |
$8.50 |
$3.52 |
$62.6 |
-59% |
RBC Capital Markets |
Affymax Inc. (AFFY) (IPO) |
12/15/06 |
$25 |
$34.04 |
$106.4 |
+36% |
|
Alexza Pharmaceuticals Inc. (ALXA) (IPO) |
3/8/06 |
$8 |
$11.39 |
$50.6 |
+42% |
RBC Capital Markets |
Genitope Corp. (GTOP) (co-lead) |
2/7/06 |
$8.50 |
$3.52 |
$62.6 |
-59% |
|
Pharmacyclics Inc. (PCYC) (co-lead) |
11/7/06 |
$4.75 |
$5.07 |
$22.9 |
+7% |
Robert W. Baird & Co. |
Cepheid Inc. (CPHD) |
3/8/06 |
$8.60 |
$8.50 |
$86 |
-1% |
|
Cerus Corp. (CERS) (co-lead) |
3/16/06 |
$8.75 |
$5.86 |
$45.3 |
-33% |
|
Illumina Inc. (ILMN) |
5/19/06 |
$25.50 |
$39.31 |
$102.6 |
+54% |
Rodman & Renshaw |
Alnylam Pharmaceuticals Inc. (ALNY) |
1/31/06 |
$13 |
$21.40 |
$66.5 |
+65% |
|
BioMarin Pharmaceutical Inc. (BMRN) |
3/24/06 |
$13 |
$16.39 |
$134.6 |
+26% |
|
Celgene Corp. (CELG) |
11/3/06 |
$51.60 |
$57.53 |
$1,032 |
+11% |
|
Omrix Bio-pharmaceuticals Inc. (OMRI) |
12/15/06 |
$32 |
$30.26 |
$48 |
-5% |
Roth Capital Partners |
Cleveland BioLabs Inc. (CBLI) (IPO; co-lead) |
7/20/06 |
$6 |
$5.04 |
$10.2 |
-16% |
Stifel Nicolaus |
Catalyst Pharmaceutical Partners Inc. (CPRX) (IPO; co-lead) |
11/9/06 |
$6 |
$4.83 |
$20.1 |
-20% |
Sunrise Securities |
Cleveland BioLabs Inc. (CBLI) (IPO; co-lead) |
7/20/06 |
$6 |
$5.04 |
$10.2 |
-16% |
Susquehanna Financial |
Iomai Corp. (IOMI) (IPO) |
2/1/06 |
$7 |
$4.98 |
$35 |
-29% |
ThinkEquity |
Advanced Magnetics Inc. (AMAG) (lead) |
3/6/06 |
$27.46 |
$59.72 |
$33.8 |
+117% |
|
Advanced Magnetics Inc. (AMAG) |
12/7/06 |
$62 |
$59.72 |
$130.4 |
-4% |
Thomas Weisel Partners |
Affymax Inc. (AFFY) (IPO) |
12/15/06 |
$25 |
$34.04 |
$106.4 |
+36% |
|
Celgene Corp. (CELG) |
11/3/06 |
$51.60 |
$57.53 |
$1,032 |
+11% |
|
Metabolix Inc. (MBLX) (IPO) |
11/17/06 |
$14 |
$18.94 |
$109.5 |
+35% |
|
Pharmacyclics Inc. (PCYC) (co-lead) |
11/7/06 |
$4.75 |
$5.07 |
$22.9 |
+7% |
|
Theravance Inc. (THRX) |
2/1/06 |
$28.50 |
$30.89 |
$131.1 |
+8% |
|
Vanda Pharmaceuticals Inc. (VNDA) (IPO) |
4/12/06 |
$10 |
$24.65 |
$59.6 |
+147% |
UBS Investment Bank |
Advanced Magnetics Inc. (AMAG) (co-lead) |
12/7/06 |
$62 |
$59.72 |
$130.4 |
-4% |
|
Arena Pharmaceuticals Inc. (ARNA) (co-lead) |
1/27/06 |
$16.90 |
$12.91 |
$179.8 |
-24% |
|
Cepheid Inc. (CPHD) (lead) |
3/8/06 |
$8.60 |
$8.50 |
$86 |
-1% |
|
Iomai Corp. (IOMI) (IPO; co-lead) |
2/1/06 |
$7 |
$4.98 |
$35 |
-29% |
|
Indevus Pharmaceuticals Inc. (IDEV) (lead) |
6/28/06 |
$4.65 |
$7.10 |
$37.43 |
+53% |
|
NeoPharm Inc. (NEOL) (lead) |
1/5/06 |
$10.20 |
$1.67 |
$41.1 |
-84% |
|
Omrix Bio\pharmaceuticals Inc. (OMRI) (IPO; co-lead) |
4/20/06 |
$10 |
$30.26 |
$39.6 |
+203% |
|
Omrix Biopharmaceuticals Inc. (OMRI) (co-lead) |
12/15/06 |
$32 |
$30.26 |
$48 |
-5% |
|
Sirna Therapeutics Inc. (RNAI) (co-lead) |
5/24/06 |
$5 |
$13** |
$51.8 |
+160% |
UBS Investment |
Valera Pharmaceuticals Inc. (VLRX) (IPO; co-lead) |
2/2/06 |
$9 |
$8.10 |
$34.8 |
-10% |
|
Vertex Pharmaceuticals Inc. (VRTX) |
9/14/06 |
$33 |
$37.42 |
$300.3 |
+13% |
Wachovia Capital Markets |
MannKind Corp. (MNKD) |
12/7/06 |
$17.42 |
$16.49 |
$400.7 |
-5% |
Westwind Partners |
Labopharm Inc. (Canada; DDSS) |
4/28/06 |
$8 |
$5.87 |
$101.2 |
-27% |
William Blair & Co. |
Cepheid Inc. (CPHD) |
3/8/06 |
$8.60 |
$8.50 |
$86 |
-1% |
WR Hambrecht + Co. |
Genitope Corp. (GTOP) (co-lead) |
2/7/06 |
$8.50 |
$3.52 |
$62.6 |
-59% |
Notes: | ||||||
* The financings in this chart include only public offerings of stock in the U.S. The data were compiled primarily from BioWorld Financial Watch's monthly financing charts covering the period from Jan. 1 to Dec. 31, 2006. The gross proceed totals include money raised through overallotment options. Offering prices were adjusted to reflect stock splits, where applicable. The issue next week will evaluate underwriters' performance. | ||||||
** Sirna Therapeutics Inc. was acquired for $13 per share on Dec. 29, 2006. | ||||||
Unless otherwise noted, shares are traded on the Nasdaq exchange. | ||||||
AMEX = American Stock Exchange; NYSE = New York Stock Exchange. |